Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

Presbia logo

About Presbia Stock (NASDAQ:LENS)

Advanced Chart

Key Stats

Today's Range
$27.98
$27.98
50-Day Range
$0.07
$0.32
52-Week Range
$0.23
$5.50
Volume
27 shs
Average Volume
122,366 shs
Market Capitalization
$482.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Receive LENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Presbia and its competitors with MarketBeat's FREE daily newsletter.

LENS Stock News Headlines

Contact Lens King Coupons
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Real and virtual images
Types of lens
Convex and concave lenses
See More Headlines

LENS Stock Analysis - Frequently Asked Questions

Presbia PLC (NASDAQ:LENS) announced its quarterly earnings data on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analysts' expectations of $0.04 million. Presbia had a negative net margin of 36,604.35% and a negative trailing twelve-month return on equity of 414.02%.

Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX) and Marinus Pharmaceuticals (MRNS).

Company Calendar

Last Earnings
8/12/2016
Today
6/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LENS
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.41 million
Net Margins
-36,604.35%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
24,103.56
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
310.87

Miscellaneous

Free Float
N/A
Market Cap
$482.07 million
Optionable
Not Optionable
Beta
2.57
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:LENS) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners